Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

When cancer enters someone’s life, grief often comes with it. It is not only the patient who feels it, but also their loved ones, including children, and even the medical staff who walk beside them. Grief in this setting is layered and deeply personal, taking many forms that are not always tied to…
Fall is a busy time for everyone — but especially for GW Cancer Center patients, who are also parents. Like any parent, they juggle carpools, homework, and daily responsibilities. But for them, all of this happens while fighting cancer and focusing on recovery.
Daniel Chen is always moving forward. His life has been a series of moves, both geographic and professional, that have brought new challenges and fresh perspectives wherever he finds himself. Born and raised in Taiwan in a family steeped in medicine, he grew up surrounded by conversations about…